- Home
- CWBC vs ITOS Comparison
CWBC vs ITOS Comparison
Compare CWBC & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- ITOS
- Stock Information
- Founded
- CWBC 1989
- ITOS 2011
- Country
- CWBC United States
- ITOS United States
- Employees
- CWBC N/A
- ITOS 173
- Industry
- CWBC Major Banks
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CWBC Finance
- ITOS Health Care
- Exchange
- CWBC Nasdaq
- ITOS Nasdaq
- Market Cap
- CWBC 398.6M
- ITOS 450.9M
- IPO Year
- CWBC 1996
- ITOS 2020
- Fundamental
- Price
- CWBC $21.36
- ITOS $10.19
- Analyst Decision
- CWBC Buy
- ITOS Hold
- Analyst Count
- CWBC 3
- ITOS 6
- Target Price
- CWBC $21.67
- ITOS $10.40
- AVG Volume (30 Days)
- CWBC 39.7K
- ITOS 1.0M
- Earning Date
- CWBC 07-17-2025
- ITOS 08-06-2025
- Dividend Yield
- CWBC 2.24%
- ITOS N/A
- EPS Growth
- CWBC 95.72
- ITOS N/A
- EPS
- CWBC 1.39
- ITOS N/A
- Revenue
- CWBC $132,829,000.00
- ITOS N/A
- Revenue This Year
- CWBC $30.64
- ITOS N/A
- Revenue Next Year
- CWBC $6.58
- ITOS N/A
- P/E Ratio
- CWBC $15.34
- ITOS N/A
- Revenue Growth
- CWBC 55.84
- ITOS 177.89
- 52 Week Low
- CWBC $15.57
- ITOS $4.80
- 52 Week High
- CWBC $22.89
- ITOS $18.01
- Technical
- Relative Strength Index (RSI)
- CWBC 69.49
- ITOS 60.66
- Support Level
- CWBC $19.97
- ITOS $10.10
- Resistance Level
- CWBC $20.36
- ITOS $10.22
- Average True Range (ATR)
- CWBC 0.48
- ITOS 0.04
- MACD
- CWBC 0.16
- ITOS -0.00
- Stochastic Oscillator
- CWBC 91.64
- ITOS 78.57
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.